P
MESO

&Partners’s Mesoblast MESO Stock Holding History

&Partners’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Buy
27,567
+621
+2% +$9.23K ﹤0.01% 2000
2026
Q1 		$414K Buy
26,946
+8,434
+46% +$140K ﹤0.01% 1804
2025
Q4 		$334K Buy
+18,512
New +$319K ﹤0.01% 1852

Other funds holding MESO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return

&Partners's MESO Position: Q2 2026 in Review

&Partners increased its Mesoblast (MESO) stake by 2.3% in Q2 2026, buying an estimated $9.23K and bringing the position to 27,567 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

&Partners first reported a position in MESO in Q4 2025 and has held it in 3 quarters since. The position peaked at $414K in Q1 2026. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • &Partners held 27,567 shares of Mesoblast worth $373K as of Q2 2026.
  • &Partners bought 621 Mesoblast shares in Q2 2026, an estimated $9.23K.
  • Mesoblast made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2000 holding.
  • &Partners first reported a position in Mesoblast in Q4 2025 and has held it in 3 quarters since.
  • &Partners's Mesoblast position peaked at $414K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.